Meta-analysis of 5 retrospective studies (218 eyes) in Coats disease: adding anti-VEGF to ablation reduced sessions to quiescence (MD 0.47), with no significant difference in final BCVA, phthisis or tractional detachment (RR 2.64, NS). Low-grade evidence.
Meta-analysisn = 218 eyes
Zhang et al. ADJUVANT ANTI-VEGF THERAPY DURING ABLATIVE TREATMENT FOR COATS DISEASE: A Systematic Review and Meta-Analysis